Hashimoto Yoshinori, Omura Hiromi, Tanaka Takayuki, Hino Norihiko, Nakamoto Shu
Department of Internal Medicine, Iwami Municipal Hospital, Tottori, Japan.
J Clin Exp Hematop. 2012;52(3):185-91. doi: 10.3960/jslrt.52.185.
A 71-year-old male underwent an upper gastrointestinal endoscopy ; as a result of a biopsy, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) was suspected. Abdominal computed tomography scan disclosed an approximately 4-cm-large mass in the ileocecal region. After ileocecal resection, the patient was diagnosed with MALT lymphoma (CD79a(+), CD20(+), CD3(-), CD5(-), CD10(-), and cyclin D1(-)). He achieved complete remission after receiving chemotherapy. However, four years after the primary onset, he was diagnosed with recurrence. Although he achieved remission again by salvage therapy, six years after the primary onset, he was referred to our hospital with second recurrence. Colonoscopy revealed the appearance of multiple lymphomatous polyposis and biopsy specimens showed monotonous proliferation of centrocyte-like cells (CD79a(+), CD20(+), CD3(-), CD5(-), CD10(-), and cyclin D1(+)), which were consistent with mantle cell lymphoma (MCL) except for CD5. The result of reactivity to cyclin D1 was different from that at initial diagnosis, so we reexamined the initial surgical specimens, the histological and histochemical features of which were proven to be the same as those of colonic biopsy specimens. Finally, the patient was diagnosed with CD5-negative MCL (marginal zone-like variant). As MALT lymphoma and MCL sometimes show similar histological features, they are difficult to distinguish from each other. It is necessary to take the possibility of this rare phenotype of MCL into consideration and to reexamine the initial diagnosis, especially if the clinical course is unusual for MALT lymphoma. This case is very interesting in view of its indolent clinical feature and phenotype.
一名71岁男性接受了上消化道内镜检查;活检结果怀疑为黏膜相关淋巴组织结外边缘区淋巴瘤(MALT淋巴瘤)。腹部计算机断层扫描显示回盲部有一个约4厘米大的肿块。回盲部切除术后,患者被诊断为MALT淋巴瘤(CD79a(+)、CD20(+)、CD3(-)、CD5(-)、CD10(-)、细胞周期蛋白D1(-))。接受化疗后他实现了完全缓解。然而,初发四年后,他被诊断为复发。尽管通过挽救治疗他再次缓解,但初发六年时,他因第二次复发被转诊至我院。结肠镜检查发现多处淋巴瘤性息肉病表现,活检标本显示中心细胞样细胞呈单调增殖(CD79a(+)、CD20(+)、CD3(-)、CD5(-)、CD10(-)、细胞周期蛋白D1(+)),除CD5外,这些与套细胞淋巴瘤(MCL)一致。细胞周期蛋白D1的反应结果与初始诊断时不同,因此我们重新检查了初始手术标本,其组织学和组织化学特征被证明与结肠活检标本相同。最终,患者被诊断为CD5阴性MCL(边缘区样变异型)。由于MALT淋巴瘤和MCL有时表现出相似的组织学特征,它们很难相互区分。有必要考虑这种罕见的MCL表型的可能性并重新审视初始诊断,特别是如果临床病程对于MALT淋巴瘤来说不寻常。鉴于其惰性的临床特征和表型,该病例非常有趣。